ArticleOncoTargets and therapy2020

Durable Response to Osimertinib in a Chinese Patient with Metastatic Lung Adenocarcinoma Harboring a Rare EGFR L858R/D761Y Compound Mutation.

Yajie Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.